首页> 美国卫生研究院文献>BMC Cancer >Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes resulting in cell death or senescence
【2h】

Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes resulting in cell death or senescence

机译:用小分子抑制剂FQI1或siRNA靶向癌基因LSF导致未对准的染色体导致有丝分子延迟导致细胞死亡或衰老

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

FQI1-treated HeLa cells exhibit mitotic defects. a Schematic of experimental protocol. Cells released from the double thymidine block in the presence of 20 μM of thymidine, plus FQI1 or vehicle, were harvested at multiple times during progression through the cell cycle. b At the indicated time points following release from the G1/S block with 0, 0.9, 1.8, or 3.6 μM of FQI1, cells were analyzed for DNA profiling by flow cytometry. Data are representative of at least three independent experiments. Separated, individual flow cytometry images are displayed in Additional File 1. c Representative time-lapse images of individual cells treated with vehicle or 1.8 μM FQI1. Numbers represent time for one particular cell in the image from nuclear envelope breakdown (designated as time = 0 for that cell). d Quantitation of mitotic time from nuclear envelop breakdown (NEB) to anaphase for the population of asynchronous cells during treatment for approximately 16 h with FQI1 or vehicle. Mitotic times (mean time in minutes +/− standard error of the mean, n) for vehicle, and 0.9 or 1.8 μM FQI1 treatments were: 48.7 +/− 1.5, 104; 84.5 +/− 4.9, 104; and 228 +/− 15, 77; respectively. Mitotic time for cells treated with 3.6 μM was not quantifiable, as those cells that entered mitosis at various points during the imaging period never reached anaphase or nuclear division by the end of the 16-h period. e Quantitation of cellular events at increasing concentrations of FQI1 during time lapse microscopy, including percentage of cells that visually rounded up as expected for mitotic entry (by phase contrast), but were delayed with condensed, but unaligned chromosomes, and the percentage that apparently underwent mitotic slippage with formation of multiple (> 2) nuclei. 120–140 cells were analyzed for each condition. f Bottom: γ-H2AX staining of HeLa cells treated with vehicle or 1.8 μM FQI1. Top: Representative image of UV-treated HeLa cells as a positive control. All images were taken at the same intensity and are representative of two independent experiments. Scale bars: 20 μm
机译:FQI1治疗的Hela细胞表现出有丝分裂缺陷。实验方案的示意图。通过细胞周期在进展期间多次收获从20μm胸苷,加上FQI1或载体的双胸苷嵌段中释放的细胞。 B在从G1 / S嵌段释放的指示时间点,通过0,0.9,1.8或3.6μm的FQi1,通过流式细胞术分析细胞进行DNA分析。数据代表至少三个独立实验。分离,单个流式细胞术图像显示在附加文件1. C用车辆或1.8μmfqi1处理的单个细胞的代表性时间流逝图像。数字代表来自核包封故障的图像中一个特定小区的时间(指定为该单元格的时间= 0)。从核被膜击穿(NEB)有丝分裂时间d定量在治疗过程中后期异步细胞群用于与FQI1或车辆约16小时。有丝分裂时间(用于车辆的平均值+/-标准误差的平均时间,N)和0.9或1.8μm的FQI1治疗:48.7 +/- 1.5,104; 84.5 +/- 4.9,104;和228 +/- 15,77;分别。有丝分裂时间为3.6μM处理的细胞没有量化的,作为在成像期间从未达到后期或核除以16小时期间结束时进入有丝分裂的各个点的那些细胞。在时间流逝显微镜期间增加FQI1浓度的细胞事件的e定量,包括随着有丝分裂入口的预期(相对对比)视觉上圆形的细胞百分比,但被缩合但未对准的染色体延迟,以及显然接受的百分比有丝分裂,具有多种(> 2)核的形成。分析120-140细胞每种条件。 F底:用载体或1.8μmF13处理的HeLa细胞的γ-H2AX染色。顶部:紫外线治疗的Hela细胞的代表性图像作为阳性对照。所有图像都以相同的强度拍摄,并且代表两个独立实验。秤条:20μm

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号